SKINPULSE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SKINPULSE Trademark

Serial Number: 79198680 • Registration: 5510296

SKINPULSE is a trademark filed by BIOFARMA, Société par actions simplifiée on August 12, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BIOFARMA, Société par actions simplifiée (2 trademarks)

50 rue Carnot

Entity Type: 34

Trademark Details

Filing Date

August 12, 2016

Registration Date

July 10, 2018

Published for Opposition

April 24, 2018

Cancellation Date

January 24, 2025

Goods & Services

Software for use in processing information from medical monitoring devices; software recorded on magnetic media or downloadable from a remote computer network for use in processing information from medical devices, deploying that information to the cloud and managing that information on a cloud computing platform; software for monitoring of physiological signals; software for the analysis, storage, and monitoring of physiological data, including diagnostic, surveillance and warning tools; apparatus for recording and transmitting physiological signals, namely, oximeters, not for medical purposes, body position sensors, not for medical use, and accelerometers; apparatus, namely, electro-textile sensors incorporated into electro-conductive clothing, for recording physiological signals, namely, oxygen saturation in blood not for medical purposes, and acceleration of the body and body position not for medical purposes, and also including electro-conductive clothing sold as a unit; personal digital assistant; transmitters of electronic signals

Medical services; medical diagnostic testing, monitoring and reporting services via electronic and telematic means

Surgical Apparatus and instruments; medical apparatus and instruments for monitoring, diagnosis, surveillance and alerts relating to heart, neurological, respiratory and physiological disorders; medical apparatus and instruments for monitoring, diagnosis, surveillance and alerts relating to heart, neurological, respiratory and physiological disorders, namely ECG (electrocardiographs); medical apparatus and instruments for monitoring, diagnosis, surveillance and alerts relating to heart, neurological, respiratory and physiological disorders, namely oximeters, ECG (electrocardiographs), body position sensors, accelerometer and also including electro-conductive clothing sold as a unit; orthopedic articles namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; medical devices and instruments for use in surgery; diagnostic devices for medical use namely, sample preparation device for medical diagnostic uses

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Apr 2, 2026 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Feb 21, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 21, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 24, 2025 INTR
CANCELLED SECTION 71
Jan 24, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 10, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 2, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 16, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 16, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 10, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 10, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 8, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 23, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 23, 2018 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Apr 20, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 4, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 4, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 8, 2018 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Feb 21, 2018 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Feb 21, 2018 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Feb 21, 2018 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 1, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 29, 2017 GNFN
FINAL REFUSAL E-MAILED
Aug 29, 2017 GNFR
FINAL REFUSAL WRITTEN
Aug 29, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2017 CRFA
ASSIGNED TO LIE
Aug 6, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2017 TROA
REFUSAL PROCESSED BY IB
Feb 3, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Jan 7, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 6, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 5, 2017 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 30, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2016 REPR